GAM Holding’s Esperion Therapeutics ESPR Stock Holding History

GAM Holding’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-70,700	Closed	-$1.98M	–	316
2021 Q1	$1.98M	Buy	+70,700	New	+$2.09M	0.09%	199
2020 Q4	–	Sell	-70,700	Closed	-$2.63M	–	290
2020 Q3	$2.63M	Hold	70,700	–	–	0.16%	180
2020 Q2	$3.63M	Hold	70,700	–	–	0.23%	137
2020 Q1	$2.23M	Sell	70,700 -17,300	-20%	-$913K	0.15%	179
2019 Q4	$5.25M	Hold	88,000	–	–	0.25%	123
2019 Q3	$3.23M	Hold	88,000	–	–	0.14%	170
2019 Q2	$4.09M	Hold	88,000	–	–	0.16%	145
2019 Q1	$3.53M	Hold	88,000	–	–	0.15%	161
2018 Q4	$4.05M	Sell	88,000 -45,800	-34%	-$2.21M	0.2%	122
2018 Q3	$5.94M	Hold	133,800	–	–	0.22%	133
2018 Q2	$5.24M	Sell	133,800 -64,800	-33%	-$3.27M	0.18%	145
2018 Q1	$14.4M	Sell	198,600 -26,400	-12%	-$1.94M	0.51%	41
2017 Q4	$14.8M	Hold	225,000	–	–	0.45%	40
2017 Q3	$11.3M	Hold	225,000	–	–	0.48%	46
2017 Q2	$10.4M	Hold	225,000	–	–	0.15%	167
2017 Q1	$7.95M	Buy	225,000 +161,000	+252%	+$3.69M	0.13%	194
2016 Q4	$801K	Hold	64,000	–	–	0.01%	659
2016 Q3	$886K	Sell	64,000 -64,000	-50%	-$725K	0.02%	631
2016 Q2	$1.26M	Buy	128,000 +64,000	+100%	+$1.06M	0.02%	620
2016 Q1	$1.08M	Hold	64,000	–	–	0.02%	612
2015 Q4	$1.43M	Hold	64,000	–	–	0.02%	599
2015 Q3	$1.51M	Buy	64,000 +20,400	+47%	+$1.28M	0.03%	567
2015 Q2	$3.56M	Buy	+43,600	New	+$4.27M	0.05%	362

Other funds holding ESPR

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

GAM Holding's ESPR Position: Q2 2021 in Review

GAM Holding sold out of Esperion Therapeutics (ESPR) in Q2 2021, closing a stake of 70,700 shares — an estimated $1.98M sold.

GAM Holding first reported a position in ESPR in Q2 2015 and held it in 23 quarters. The position peaked at $14.8M in Q4 2017. 142 funds tracked by Wall St. Rank hold ESPR as of Q2 2021.

GAM Holding reported no remaining Esperion Therapeutics position as of Q2 2021 after selling out during the quarter.
GAM Holding sold 70,700 Esperion Therapeutics shares in Q2 2021, an estimated $1.98M.
GAM Holding first reported a position in Esperion Therapeutics in Q2 2015 and held it in 23 quarters.
GAM Holding's Esperion Therapeutics position peaked at $14.8M in Q4 2017.
142 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2021.

Based on GAM Holding's 13F filing for Q2 2021, filed 9 Aug 2021.